Logo image of BRM.CA

BIOREM INC (BRM.CA) Stock Fundamental Analysis

TSX-V:BRM - TSX Venture Exchange - CA09068G1046 - Common Stock - Currency: CAD

1.92  +0.06 (+3.23%)

Fundamental Rating

8

We assign a fundamental rating of 8 out of 10 to BRM. BRM was compared to 24 industry peers in the Commercial Services & Supplies industry. BRM gets an excellent profitability rating and is at the same time showing great financial health properties. BRM is growing strongly while it also seems undervalued. This is an interesting combination With these ratings, BRM could be worth investigating further for value and growth and quality investing!.


Dividend Valuation Growth Profitability Health

9

1. Profitability

1.1 Basic Checks

In the past year BRM was profitable.
In the past year BRM had a positive cash flow from operations.
Each year in the past 5 years BRM has been profitable.
In the past 5 years BRM always reported a positive cash flow from operatings.
BRM.CA Yearly Net Income VS EBIT VS OCF VS FCFBRM.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1M -1M 2M 3M 4M

1.2 Ratios

BRM's Return On Assets of 22.73% is amongst the best of the industry. BRM outperforms 100.00% of its industry peers.
With an excellent Return On Equity value of 55.66%, BRM belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
Looking at the Return On Invested Capital, with a value of 44.99%, BRM belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.
Measured over the past 3 years, the Average Return On Invested Capital for BRM is significantly above the industry average of 7.99%.
The last Return On Invested Capital (44.99%) for BRM is above the 3 year average (25.13%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 22.73%
ROE 55.66%
ROIC 44.99%
ROA(3y)9.17%
ROA(5y)8.76%
ROE(3y)32.25%
ROE(5y)35.65%
ROIC(3y)25.13%
ROIC(5y)23.46%
BRM.CA Yearly ROA, ROE, ROICBRM.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40 60 80

1.3 Margins

BRM has a Profit Margin of 11.99%. This is amongst the best in the industry. BRM outperforms 87.50% of its industry peers.
BRM's Profit Margin has improved in the last couple of years.
BRM has a better Operating Margin (16.65%) than 87.50% of its industry peers.
In the last couple of years the Operating Margin of BRM has grown nicely.
BRM's Gross Margin of 31.68% is in line compared to the rest of the industry. BRM outperforms 58.33% of its industry peers.
In the last couple of years the Gross Margin of BRM has grown nicely.
Industry RankSector Rank
OM 16.65%
PM (TTM) 11.99%
GM 31.68%
OM growth 3Y7.19%
OM growth 5YN/A
PM growth 3Y15.35%
PM growth 5YN/A
GM growth 3Y1.79%
GM growth 5Y2.67%
BRM.CA Yearly Profit, Operating, Gross MarginsBRM.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20 30

9

2. Health

2.1 Basic Checks

BRM has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
Compared to 1 year ago, BRM has more shares outstanding
BRM has less shares outstanding than it did 5 years ago.
The debt/assets ratio for BRM has been reduced compared to a year ago.
BRM.CA Yearly Shares OutstandingBRM.CA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M
BRM.CA Yearly Total Debt VS Total AssetsBRM.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M

2.2 Solvency

An Altman-Z score of 4.79 indicates that BRM is not in any danger for bankruptcy at the moment.
BRM has a Altman-Z score of 4.79. This is amongst the best in the industry. BRM outperforms 95.83% of its industry peers.
BRM has a debt to FCF ratio of 0.72. This is a very positive value and a sign of high solvency as it would only need 0.72 years to pay back of all of its debts.
Looking at the Debt to FCF ratio, with a value of 0.72, BRM belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.
A Debt/Equity ratio of 0.30 indicates that BRM is not too dependend on debt financing.
The Debt to Equity ratio of BRM (0.30) is better than 87.50% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.3
Debt/FCF 0.72
Altman-Z 4.79
ROIC/WACC6.15
WACC7.31%
BRM.CA Yearly LT Debt VS Equity VS FCFBRM.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5M 10M

2.3 Liquidity

A Current Ratio of 1.91 indicates that BRM should not have too much problems paying its short term obligations.
With an excellent Current ratio value of 1.91, BRM belongs to the best of the industry, outperforming 87.50% of the companies in the same industry.
BRM has a Quick Ratio of 1.66. This is a normal value and indicates that BRM is financially healthy and should not expect problems in meeting its short term obligations.
BRM has a Quick ratio of 1.66. This is amongst the best in the industry. BRM outperforms 83.33% of its industry peers.
Industry RankSector Rank
Current Ratio 1.91
Quick Ratio 1.66
BRM.CA Yearly Current Assets VS Current LiabilitesBRM.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M

8

3. Growth

3.1 Past

BRM shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 31.30%, which is quite impressive.
The Earnings Per Share has been growing by 32.08% on average over the past years. This is a very strong growth
BRM shows a strong growth in Revenue. In the last year, the Revenue has grown by 72.21%.
BRM shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 12.63% yearly.
EPS 1Y (TTM)31.3%
EPS 3Y32.08%
EPS 5YN/A
EPS Q2Q%-92.76%
Revenue 1Y (TTM)72.21%
Revenue growth 3Y15.2%
Revenue growth 5Y12.63%
Sales Q2Q%-23.69%

3.2 Future

BRM is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 23.54% yearly.
Based on estimates for the next years, BRM will show a quite strong growth in Revenue. The Revenue will grow by 8.45% on average per year.
EPS Next Y15.79%
EPS Next 2Y23.54%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year7.05%
Revenue Next 2Y8.45%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

Although the future EPS growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
BRM.CA Yearly Revenue VS EstimatesBRM.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 10M 20M 30M 40M
BRM.CA Yearly EPS VS EstimatesBRM.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2024 2025 2026 0.05 0.1 0.15 0.2 0.25

9

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 10.67, which indicates a very decent valuation of BRM.
95.83% of the companies in the same industry are more expensive than BRM, based on the Price/Earnings ratio.
Compared to an average S&P500 Price/Earnings ratio of 26.25, BRM is valued rather cheaply.
The Price/Forward Earnings ratio is 8.47, which indicates a very decent valuation of BRM.
Based on the Price/Forward Earnings ratio, BRM is valued cheaper than 83.33% of the companies in the same industry.
When comparing the Price/Forward Earnings ratio of BRM to the average of the S&P500 Index (22.15), we can say BRM is valued rather cheaply.
Industry RankSector Rank
PE 10.67
Fwd PE 8.47
BRM.CA Price Earnings VS Forward Price EarningsBRM.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of BRM indicates a rather cheap valuation: BRM is cheaper than 100.00% of the companies listed in the same industry.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of BRM indicates a rather cheap valuation: BRM is cheaper than 91.67% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 5.99
EV/EBITDA 3.33
BRM.CA Per share dataBRM.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0.5 1 1.5 2 2.5

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
The excellent profitability rating of BRM may justify a higher PE ratio.
A more expensive valuation may be justified as BRM's earnings are expected to grow with 23.54% in the coming years.
PEG (NY)0.68
PEG (5Y)N/A
EPS Next 2Y23.54%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

BRM does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

BIOREM INC

TSX-V:BRM (5/30/2025, 7:00:00 PM)

1.92

+0.06 (+3.23%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCommercial & Professional Services
GICS IndustryCommercial Services & Supplies
Earnings (Last)05-15 2025-05-15
Earnings (Next)08-25 2025-08-25
Inst Owners0.22%
Inst Owner ChangeN/A
Ins Owners1.86%
Ins Owner ChangeN/A
Market Cap30.95M
Analysts84.44
Price Target4.08 (112.5%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-11.11%
PT rev (3m)-11.11%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-1.99%
Revenue NY rev (3m)-1.99%
Valuation
Industry RankSector Rank
PE 10.67
Fwd PE 8.47
P/S 0.67
P/FCF 5.99
P/OCF 5.72
P/B 3.11
P/tB 3.11
EV/EBITDA 3.33
EPS(TTM)0.18
EY9.38%
EPS(NY)0.23
Fwd EY11.8%
FCF(TTM)0.32
FCFY16.7%
OCF(TTM)0.34
OCFY17.49%
SpS2.87
BVpS0.62
TBVpS0.62
PEG (NY)0.68
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 22.73%
ROE 55.66%
ROCE 59.39%
ROIC 44.99%
ROICexc 102.59%
ROICexgc 102.59%
OM 16.65%
PM (TTM) 11.99%
GM 31.68%
FCFM 11.18%
ROA(3y)9.17%
ROA(5y)8.76%
ROE(3y)32.25%
ROE(5y)35.65%
ROIC(3y)25.13%
ROIC(5y)23.46%
ROICexc(3y)41.23%
ROICexc(5y)N/A
ROICexgc(3y)41.23%
ROICexgc(5y)N/A
ROCE(3y)33.17%
ROCE(5y)30.97%
ROICexcg growth 3Y-30.69%
ROICexcg growth 5YN/A
ROICexc growth 3Y-30.69%
ROICexc growth 5YN/A
OM growth 3Y7.19%
OM growth 5YN/A
PM growth 3Y15.35%
PM growth 5YN/A
GM growth 3Y1.79%
GM growth 5Y2.67%
F-Score7
Asset Turnover1.9
Health
Industry RankSector Rank
Debt/Equity 0.3
Debt/FCF 0.72
Debt/EBITDA 0.36
Cap/Depr 46.44%
Cap/Sales 0.53%
Interest Coverage 250
Cash Conversion 65.81%
Profit Quality 93.26%
Current Ratio 1.91
Quick Ratio 1.66
Altman-Z 4.79
F-Score7
WACC7.31%
ROIC/WACC6.15
Cap/Depr(3y)93.69%
Cap/Depr(5y)79.96%
Cap/Sales(3y)1.3%
Cap/Sales(5y)1.12%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)31.3%
EPS 3Y32.08%
EPS 5YN/A
EPS Q2Q%-92.76%
EPS Next Y15.79%
EPS Next 2Y23.54%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)72.21%
Revenue growth 3Y15.2%
Revenue growth 5Y12.63%
Sales Q2Q%-23.69%
Revenue Next Year7.05%
Revenue Next 2Y8.45%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y431.47%
EBIT growth 3Y23.48%
EBIT growth 5YN/A
EBIT Next Year38.31%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y113.08%
FCF growth 3Y-3.66%
FCF growth 5Y6.73%
OCF growth 1Y71.38%
OCF growth 3Y-0.86%
OCF growth 5Y7.83%